Navigation Links
Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing
Date:5/26/2010

rmation about the company and its products, please visit www.horizonpharma.com.

Forward Looking Statements

This press release includes forward-looking statements that are subject to risks, uncertainties and other factors.  All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, but not limited to, any statements regarding the future of any product or product candidate, including the timing of the submission of regulatory filings for approval of such products or product candidates and the timing of any regulatory approval; and any statements of the plans, strategies and objectives of management for future operations of the company.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, the inherent risks of product development and approval, clinical outcomes, regulatory risks, risks related to proprietary rights, market acceptance and competition and risks associated with the company's ability to obtain additional capital to support its planned operations.


'/>"/>
SOURCE Horizon Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
2. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
5. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
6. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
7. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
8. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
9. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
10. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
11. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... initiated a phase I clinical trial in patients ... safety, tolerability, and immunogenicity of INO-3106. This immunotherapy ... most aerodigestive cancers. Aerodigestive cancers affect ... and parts of the esophagus and windpipe. The ...
(Date:9/22/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... TUV-SUD and The Medicinal Evaluation Board of ... its request for a label expansion for Neutrolin, ... in July 2013 for use in the prevention ...
(Date:9/22/2014)... 2014  Seres Health, a clinical-stage therapeutics company developing ... today announced that it has been named by ... companies, designating it as one of the most promising ... "Amid a great deal of ain,t-it-cool science in microbiomics, ... to practical therapeutic development," says Damian Garde , ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... BALTIMORE, Feb. 4, 2011 Ameritox®, the nation,s ... to advance its industry leadership position by strengthening ... the past twelve months.  Through significant investments in ... capabilities, Ameritox has reached several milestones – including ...
... R.I., Feb. 4, 2011 MEDfx Corporation today announced ... among providers using a combination of the standards and ... CONNECT Gateway. MEDfx is participating in, and is a ... of the National Coordinator of Health IT.  The MEDfx ...
Cached Medicine Technology:Ameritox® Continues to Advance Industry Leadership 2Ameritox® Continues to Advance Industry Leadership 3Ameritox® Continues to Advance Industry Leadership 4MEDfx to Harmonize the Direct Project With CONNECT 2MEDfx to Harmonize the Direct Project With CONNECT 3
(Date:9/22/2014)... a very familiar "lub-dub" pattern that speeds up or ... pattern itself isn,t as regular as you might think. ... vary even at a "constant" heart rateand that variability, ... Reduced heart rate variability (HRV) has been found to ... congestive heart failure and inflammation. For athletes, a drop ...
(Date:9/22/2014)... 22, 2014 WHO: LiveOps, Inc., ... customer service solutions. , WHAT: The 10th annual ... customer care for the connected consumer. Constant change ... offer new challenges and opportunities for customer experience ... identify best practices, network and learn from fellow ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... child,s brain processes sounds might help identify the severity ... Observing children,s brainwaves may also allow identification of autism ... "The finding that the brain,s response to certain ... hugely promising," said senior researcher Sophie Molholm, an associate ...
(Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... California for a three-day conference to discuss brain-related ... brain injury from concussions and neurodegenerative disorders. ... medical director affiliated with a Silverado memory care ... of dedicated expertise in memory care, hosts the ...
(Date:9/22/2014)... The report segments the global physiotherapy ... geography. The equipment segment accounted for a lion’s ... product. However, the accessories segment is expected to ... period, owing to the rising demand of physiotherapy ... segments are the fastest-growing segments in the physiotherapy ...
Breaking Medicine News(10 mins):Health News:Variability keeps the body in balance 2Health News:Variability keeps the body in balance 3Health News:Variability keeps the body in balance 4Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5
... 4 BasicPlus Health,Insurance of Roswell, Ga., announced ... Companion Global Healthcare Inc. of Columbia, S.C., to,include ... most popular,limited benefit health insurance plans., The ... and BasicPlus (for individuals) limited benefit plans have ...
... outlines major issues and best practices for handling fresh, produce that every ... ... to know., ATLANTA, June 4 Fresh produce safety ... public awareness and,industry concern. At its biennial meeting in San Antonio, Texas, ...
... American Society for Investigative Pathology (ASIP) is pleased ... Professor of Pathology and Microbiology-Immunology at Northwestern University ... Amgen Outstanding Investigative Award, a prestigious annual award ... Amgen. Dr. Engman presented his paper, "Pathogenesis ...
... used chlorinated pesticides on more than 100 days in ... to researchers from the National Institutes of Health (NIH). ... from a 20 percent to a 200 percent increase ... Institute of Environmental Health Sciences (NIEHS) and the National ...
... LARGO, Fla., June 4 Unilens Vision ... UVI), which develops,licenses, manufactures, distributes and markets ... program for all Unilens GP (Gas Permeable),products., ... Professional,s Specialty Contact Lens,Company", continues its tradition ...
... 4th International Forum on Disability Management Will be Held in Berlin ... from 22 ... employees,capacity for work following sickness and disablement? Experts from,throughout the world will ... is to be held at the Berlin,Congress Centre from 22 to 24 ...
Cached Medicine News:Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2Health News:Retaining Employees' Capacity For Work Following Sickness 2
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
Medicine Products: